# EDGAR Filing Document

**Accession Number:** 0001569205
**File Stem:** 0001520023-25-000007
**Filing Date:** 2025-8
**Character Count:** 7976
**Document Hash:** 53013b0ab1f8099179d17dcaf0251dbc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001520023-25-000007.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001520023-25-000007

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250822

**EFFECTIVENESS DATE**: 20250822

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fundsmith LLP
- **CENTRAL INDEX KEY:** 0001569205

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 0313

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-15226
- **FILM NUMBER:** 251242552

**BUSINESS ADDRESS:**
- **STREET 1:** 33 CAVENDISH SQUARE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1G 0PW
- **BUSINESS PHONE:** 44-020-3551-6339

**MAIL ADDRESS:**
- **STREET 1:** 33 CAVENDISH SQUARE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1G 0PW

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001569205

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [x]

## N-PX: Cover Page

**Name of reporting person:** Fundsmith LLP

**Address:** 33 Cavendish Square, London, X0 W1G 0PW

**Telephone number:** 442034050608

**Name of agent for service:** Addition Compliance Limited

**Agent Address:** 51 Holland Street, London, X0 W8 7JB

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-15226

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 213800M2ZZU4WORQU863

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                    | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                    | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| THE CLOROX COMPANY                | 189054109 | 11/20/2024     | Advisory Vote to Approve Executive Compensation.                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         613497 |                0 | FOR         |                                   613497 | FOR                         |  |
| MSCI INC.                         | 55354G100 | 04/22/2025     | To approve, by advisory vote, our executive compensation.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         166619 |                0 | AGAINST     |                                   166619 | AGAINST                     |  |
| SABRE CORPORATION                 | 78573M104 | 04/23/2025     | To hold an advisory vote on the compensation of our named executive officers.                                                                       | SECTION 14A SAY-ON-PAY VOTES |       21499095 |                0 | FOR         |                                 21499095 | FOR                         |  |
| GRACO INC.                        | 384109104 | 04/25/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers as disclosed in the Proxy Statement.                       | SECTION 14A SAY-ON-PAY VOTES |        1139641 |                0 | AGAINST     |                                  1139641 | AGAINST                     |  |
| PAYCOM SOFTWARE, INC.             | 70432V102 | 05/05/2025     | Advisory approval of the compensation of the Company's named executive officers.                                                                    | SECTION 14A SAY-ON-PAY VOTES |         413510 |                0 | AGAINST     |                                   413510 | AGAINST                     |  |
| EQUIFAX INC                       | 294429105 | 05/08/2025     | Advisory vote to approve named executive officer compensation ("say-on-pay").                                                                       | SECTION 14A SAY-ON-PAY VOTES |         235505 |                0 | AGAINST     |                                   235505 | AGAINST                     |  |
| CHOICE HOTELS INTERNATIONAL, INC. | 169905106 | 05/15/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                    | SECTION 14A SAY-ON-PAY VOTES |         733892 |                0 | AGAINST     |                                   733892 | AGAINST                     |  |
| MEDPACE HOLDINGS, INC.            | 58506Q109 | 05/16/2025     | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting. | SECTION 14A SAY-ON-PAY VOTES |         127537 |                0 | AGAINST     |                                   127537 | AGAINST                     |  |
| VERISK ANALYTICS, INC.            | 92345Y106 | 05/20/2025     | To approve executive compensation on an advisory, non-binding basis.                                                                                | SECTION 14A SAY-ON-PAY VOTES |         330624 |                0 | AGAINST     |                                   330624 | AGAINST                     |  |
| CATALYST PHARMACEUTICALS, INC.    | 14888U101 | 05/20/2025     | To approve, on an advisory basis, the 2024 compensation of our named executive officers.                                                            | SECTION 14A SAY-ON-PAY VOTES |        2151274 |                0 | AGAINST     |                                  2151274 | AGAINST                     |  |
| VERISIGN, INC.                    | 92343E102 | 05/22/2025     | To approve, on an advisory basis, the Company's executive compensation.                                                                             | SECTION 14A SAY-ON-PAY VOTES |         570035 |                0 | AGAINST     |                                   570035 | AGAINST                     |  |
| EXPONENT, INC.                    | 30214U102 | 06/05/2025     | To approve, on an advisory basis, the fiscal 2024 compensation of the Company's named executive officers.                                           | SECTION 14A SAY-ON-PAY VOTES |         836477 |                0 | FOR         |                                   836477 | FOR                         |  |
| QUALYS, INC.                      | 74758T303 | 06/11/2025     | To approve, on an advisory and non-binding basis, the compensation of Qualys, Inc.'s named executive officers as described in the Proxy Statement.  | SECTION 14A SAY-ON-PAY VOTES |         718602 |                0 | FOR         |                                   718602 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Fundsmith LLP

**By (Signature):** Tom Armstrong

**By (Printed Signature):** Tom Armstrong

**By (Title):** Director

**Date:** 08/08/2025